Webinar to discuss EMBARK trial of gene therapy delandistrogene moxeparvovec to treat DMD

Our webinar to discuss the results of the EMBARK trial of Duchenne muscular dystrophy (DMD) gene therapy delandistrogene moxeparvovec (Elevidys).
It was led by Professor Francesco Muntoni, Professor of Paediatric Neurology at Great Ormond Street Hospital.
We ran it jointly with the NorthStar Network of DMD specialists, Muscular Dystrophy UK and Action Duchenne.

[@rameshkannarameshkanna7522]

Curable or not curable DMD ducenne muscular dystrophy tell us